Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 6
2005 5
2006 8
2007 16
2008 10
2009 17
2010 22
2011 30
2012 28
2013 32
2014 23
2015 33
2016 20
2017 17
2018 16
2019 15
2020 24
2021 17
2022 10
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Results by year

Filters applied: . Clear all
Page 1
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective.
Houda I, Dickhoff C, Uyl-de Groot CA, Damhuis RAM, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. Houda I, et al. Among authors: senan s. Lancet Reg Health Eur. 2024 Mar 1;38:100841. doi: 10.1016/j.lanepe.2024.100841. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476749 Free PMC article. Review.
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe.
Houda I, Dickhoff C, Uyl-de Groot CA, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. Houda I, et al. Among authors: senan s. Lancet Reg Health Eur. 2024 Mar 4;38:100840. doi: 10.1016/j.lanepe.2024.100840. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476748 Free PMC article. Review.
Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases.
Ugurluer G, Schneiders FL, Corradini S, Boldrini L, Kotecha R, Kelly P, Portelance L, Camilleri P, Ben-David MA, Poiset S, Marschner SN, Panza G, Kutuk T, Palacios MA, Castelluccia A, Zoto Mustafayev T, Atalar B, Senan S, Ozyar E. Ugurluer G, et al. Among authors: senan s. Clin Transl Radiat Oncol. 2024 Feb 29;46:100756. doi: 10.1016/j.ctro.2024.100756. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38450219 Free PMC article.
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET.
Pouw JEE, Hashemi SMS, Huisman MC, Wijngaarden JE, Slebe M, Oprea-Lager DE, Zwezerijnen GJC, Vugts D, Ulas EB, de Gruijl TD, Radonic T, Senan S, Menke-van der Houven van Oordt CW, Bahce I. Pouw JEE, et al. Among authors: senan s. J Immunother Cancer. 2024 Feb 1;12(2):e007659. doi: 10.1136/jitc-2023-007659. J Immunother Cancer. 2024. PMID: 38302416 Free PMC article.
Evaluation of post-lung SABR imaging: A proposed pathway.
Aurélie B, Famke S, Suresh S. Aurélie B, et al. Among authors: suresh s. Radiother Oncol. 2024 Mar;192:110083. doi: 10.1016/j.radonc.2024.110083. Epub 2024 Jan 11. Radiother Oncol. 2024. PMID: 38216087 No abstract available.
324 results